Despite several medical therapies currently available to treat Crohn disease, many patients still undergo surgical treatment. Benjamin Cohen, MD, co-section head and clinical director of the Department of...
In this Q&A, Adam Faye, MD, MS, discusses the implications of his team’s study examining the relationship between antibiotic use and onset of ulcerative colitis and Crohn disease in adults aged 60 years...
Brindusa Truta, MAS, MD, from Johns Hopkins Medicine, answers our questions about her study that evaluated pregnancy outcomes among mothers with IBD who discontinued therapy with infliximab early vs late...
Brindusa Truta, MAS, MD, from Johns Hopkins Medicine, answers our questions about her study that evaluated pregnancy outcomes among mothers with IBD who discontinued therapy with infliximab early vs late...
Florian Rieder, MD, from Cleveland Clinic, answers our questions about the current management of strictures in Crohn disease, the need for antifibrotic medications, and more.
Stephen Hanauer, MD, from Northwestern Medicine, answers our questions about the use of biosimilars in the management of IBD ahead of his presentation at the Advances in Inflammatory Bowel Diseases (AIBD)...
Stephen Hanauer, MD, from Northwestern Medicine, answers our questions about the use of biosimilars in the management of IBD ahead of his presentation at the Advances in Inflammatory Bowel Diseases (AIBD)...
David T. Rubin, MD, lead author of the ACG Clinical Guideline: Ulcerative Colitis in Adults, answers our questions about what’s new in the guidelines for the management of adults with ulcerative colitis. ...
